Implantable cardioverter-defibrillators in cardiovascular care: Technologic advances and new indications

Current Opinion in Critical Care

Volumn 9, Issue 5, 2003, Pages 362-368

  Rao, B Hygriv ^a,b   Saksena, Sanjeev ^b,c,d  

^a Electrophysiology Research Foundation   (United States)

^b Atlantic Health   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d NONE   (United States)

Author keywords

Atrial fibrillation; Biventricular pacing; Electromagnetic interference; Implantable defibrillators

Indexed keywords

ASYSTOLE; BIOSAFETY; BRADYCARDIA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEFIBRILLATION; DEFIBRILLATOR; DEVICE; DISEASE CONTROL; ELECTROMAGNETIC FIELD; GENERAL CONDITION IMPROVEMENT; HEALTH STATUS; HEART ARREST; HEART ATRIUM; HEART ATRIUM FLUTTER; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PACING; HEART RHYTHM; HEART VENTRICLE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HOSPITALIZATION; HUMAN; IMPLANTATION; PATIENT CARE; POPULATION; PRESCRIPTION; PRIMARY PREVENTION; QUALITY OF LIFE; REVIEW; SCIENCE; SUDDEN DEATH; SURVIVAL; SYMPTOMATOLOGY; TACHYCARDIA; TECHNOLOGY; TREATMENT INDICATION;

ATRIAL FIBRILLATION; CELLULAR PHONE; CLINICAL TRIALS; CORONARY DISEASE; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROMAGNETIC FIELDS; EQUIPMENT FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; MAGNETIC RESONANCE IMAGING; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0141562260     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200310000-00005     Document Type: Review

References (50)

1. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997, 337:1576-1583.
2. Moss AJ, Hall WJ, Cannom DS, et al.: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators N Engl J Med 1996, 335:1933-1940.
3. Connolly SJ, Gent M, Roberts RS, et al.: Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000, 101:1297-1305.
4. Lehman MH, Steinman RT, Schuger CD, et al.: The automatic implantable cardioverter defibrillator as the treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction. Am J Cardiol 1998, 62:803.
5. Boriani G, Biffi M, Padeletti L, et al.: Effects of consistent atrial pacing and atrial rate stabilization, two pacing algorithms to suppress recurrent paroxysmal atrial fibrillation in brady-tachy syndrome. Eur Heart J 2001, 5:33-44.
6. Saksena S, Prakash A, Ziegler P, et al.: Improved suppression of recurrent atrial fibrillation with dual site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002, 40:1140-1150.
7. Stellbrink C, Auricchio A, Diem B, et al.: Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia. Am J Cardiol 1999, 83:143D-150D.
8. Seidl K, Jung W, Schwacke H, et al.: Clinical experience with implantable atrial defibrillator cardioverter in patents with fibrillation. Metrix Investigators. Z Kardiol 1999, 88:574-581.
9. Goldman S, Johnson G, Cohn J, et al.: Mechanisms of death in heart failure. Circulation 1993, 87:V124-V131.
10. Tchou PJ, Kadri N, Anderson J, et al.: Automatic implantable cardioverter defibrillators and survival in patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Intern Med 1988, 109:529-534. This is one of the earliest articles on the benefit of defibrillators in LV dysfunction.
11. Axtell K, Tchou P, Akhtar M: Survival in patients with depressed left ventricular function treated by implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1991, 14:291-296.
12. Mehta D, Saksena S, Krol RB, et al.: Device use patterns and clinical outcome of implantable cardioverter defibrillator patients with moderate and severe impairment of left ventricular function. Pacing Clin Electrophysiol 1993, 16:179-185.
13. Domanski MJ, Saksena S, Epstein AE, et al.: Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. J Am Coll Cardiol 1999, 34:1090-1095.
14. Moss AJ: Implantable cardioverter defibrillator therapy: The sickest patients benefit the most. Circulation 2000, 101:1638-1640.
15. Sheldon R, Connoly S, Krahn AA, et al.: Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation 2000, 101:1660-1664.
16. Prakash A, Saksena S, Ziegler P, et al.: DAPPAF Investigators. Dual site atrial pacing for prevention of atrial fibrillation (DAPPAF) trial: echocardiographic evaluation of atrial and ventricular function during a randomized trial of support, High right atrial and dual site right atrial pacing. Pacing Clin Electrophysiol 2001, 24:579.
17. Wilkoff BL, Cook JR, Epstein AE: Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and WI Implantable Defibrillator (DAVID) Trial. JAMA 2002, 288:3115-3131.
18. Gras D, Leclercq C, Anthony SL, et al.: Cardiac Resynchronization therapy in advanced heart failure the multicenter InSync Clinical Study. Eur J Heart Failure 2002, 4:311-320.
19. Gras D, Mabo P, Tang T, et al.: Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol 1998, 21:2249-2255.
20. Kuhlkamp V: Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. J Am Coll Cardiol 2002, 39:790-797. This clinical Outcome study shows the efficacy of combining biventricular pacing with ICD therapy.
21. Feldman A, Bristow MR, for the Companion Investigators: Comparison of medical therapy, pacing, and defibrillation in chronic heart failure. Presented at the 52nd Annual Scientific sessions 2003. A large trial demonstrates mortality benefits by incorporating defibrillatory capacity to biventricular pacing.
22. Lam C, Rose M, Jaeger F, et al.: Wide QRS duration predicts inducibility of sustained ventricular arrhythmia. Circulation 2000, 102(suppl II):11-675.
23. Amiodarone Trials Meta-Analysis Investigators: Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomized trials. Lancet 1997, 350:1417-1424.
24. Moss AJ, Zareba W, Hall WJ, et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877-883. MADIT II showed the benefits of ICD therapy used as primary prevention in selected patients with LV dysfunction after myocardial infarction.
25. Hohnloser SH, Connolly SJ, Kuck KH, et al.: The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): study protocol. Am Heart J 2000, 140:735-739.
26. Kligenheben T, Zabel M: D'Agostino RB, et al. Predictive value of T-wave alternans Zabel, predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet 2000, 356:651-652.
27. Armoundas AA, Tomaselli GF, Esperer HD: Pathophysiological basis and clinical application of T-wave alternans. J Am Coll Cardiol 2002, 40:207-217. This a comprehensive summary of applications of a new noninvasive marker of SCD.
28. Ikeda T, Saito H, Tanno K, et al.: T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. Am J Cardiol 2002, 89:79-82.
29. Tapanainen JM, Still AM, Airaksinen KEJ, et al.: Prognostic significance of risk stratifiers of mortality, including T-wave alternans, after acute myocardial infarction results of a prospective follow-up study. J Cardiovasc Electrophysiol 2001, 12:645-652.
30. Platt SB, Virgins JM, Albrecht P, et al.: Occult T-wave alternans in long QT syndrome. J Cardiovasc Electrophysiol 1996, 7:144-148.
31. Gold MR, Bloomfield DM, Anderson KP, et al.: A programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 2000, 36:2247-2253.
32. Schoels W, Swerdlow CD, Jung W, et al.: Worldwide clinical experience with a new dual chamber implantable cardioverter-defibrillator system. J Cardiovasc Electrophysiol 2001, 12:521-528.
33. Ricci R, Pignalberi C, Disertori M, et al.: Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life threatening ventricular tachyarrhythmias. Eur Heart J 2002, 23:1471-1479. Italian trial with the dual atrioventricular defibrillator showed the benefits of atrial pacing and defibrillation in atrial tachyarrhythmias.
34. Gold MR, Sulke N, Schwartzman DS, et al.: Clinical experience with a dual chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2001, 12:1247-1253.
35. Kolb C, Schmeider S, Schmitt C: Inappropriate shock delivery due to interference between a washing machine and an implantable cardioverter defibrillator. J Interv Cardiac Electrophysiol 2002, 7:255-256.
36. Sabate X, Moure C, Nicholas J, et al.: Washing machine associated 50Hz detected as ventricular fibrillation by an implanted cardioverter defibrillator. Pacing Clin Electrophysiol 2001, 24:1281-1283.
37. Mathew P, Lewis C, Neglia J, et al.: Interaction between electronic article surveillance systems and implantable defibrillators: insights have a fourth generation ICD. Pacing Clin Electrophysiol 1997, 20:2857-2859.
38. Chiladakis JA, Davlouros P, Agelopoulos G, et al.: In-vivo testing of digital cellular telephones in patients with implantable cardioverter-defibrillators. Eur Heart J 2001, 22:1337-1342.
39. Hayes DL, Wang PJ, Reynolds DW, et al.: Interference with cardiac pacemakers by cellular telephones. N Engl J Med 1997, 336:1473-1479.
40. Groh W, Boschee SA, Engelstein ED, et al.: Interaction between electronic surveillance systems and implantable cardioverter defibrillators. Circulation 1999, 100:387-392.
41. Lauck G, Von Smekal A, Wolke S, et al.: Effects of nuclear magnetic resonance imaging on cardiac pacemakers. Pacing Clin Electrophysiol 1995, 18:1549-1555.
42. Rodriguez F, Filimonov A, Henning A, et al.: Radiation-induced effects in multi-programmable pacemakers and implantable defibrillators. Pacing Clin Electrophysiol 1991, 14:2143-2153.
43. Auricchio A: Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002, 39:2026-2033.
44. Linde C, Braunschweig F, Gadler F, et al.: Long-term improvements in quality of life by biventricular pacing in patients with chronic heart failure. Results from the Multisite Stimulation in Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002, 40:111-118.
45. McIvor ME, Redding J, Floden E, et al.: Study of pacemaker and implantable cardioverter-defibrillator triggering by electronic article surveillance devices (SPICED TEAS). Pacing Clin Electrophysiol 1998, 21:1847-1861.
46. Afinsen OG, Berntsen RF, Aass H, et al.: Implantable cardioverter defibrillator dysfunction during and after magnetic resonance imaging. Pacing Clin Electrophysiol 2002, 25:1400-1402.
47. Chung MK, Streem SB, Ching E: Effects of extracorporeal shock wave lithotripsy on tiered therapy implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1999, 22:738-742.
48. Kufer R, Thamasett S, Volkmer B: New-generation lithotriptors for treatment of patients with implantable cardioverter defibrillator. Experimental approach and review of literature. J Endourol 2001, 15:479-484.
49. Pyatt JR, Trenbath D, Chester M: The simultaneous use of a biventricular implantable cardioverter defibrillator (ICD) and transcutaneous electrical nerve stimulation (TENS) unit: implications for device interaction. Europace 2003, 5:91-93. An interesting case report discusses late manifestation of electromagnetic interference on ICD functioning.
50. Burke MC, Kopp DE, Alberts M: Effect of radiofrequency current on previously implanted pacemaker and defibrillator ventricular lead systems. J Electrocardiol 2001, 34(suppl):143-148.